Autoimmune ovarian disease: Mechanism of disease induction and prevention

Current Opinion in Immunology

Volumn 9, Issue 6, 1997, Pages 839-845

  Tung, K S K ^a   Lou, Y H ^a   Garza, K M ^a   Teuscher, C ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; FEMALE; GENE LOCUS; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MOLECULAR MIMICRY; MOUSE; NONHUMAN; OVARY DISEASE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0031460118     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80187-2     Document Type: Article

References (61)

1. Gery I, Streilein JW: Autoimmunity in the eye and its regulation. Curr Opin Immunol 1994, 6:938-945.
2. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA: CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996, 5:7-16.
3. Tung KSK, Lu C: Immunologic basis of reproductive failure. In Pathology of Reproductive Failure. Edited by Klaus Ft, Damjanov I, Kaufmart N. New York: Williams and Wilking. Inc: 1991:308-333.
4. Dean J: Biology of mammalian fertilization: role of zona pellucida. J Clin Invest 1992, 89:1055-1059.
5. Rhim SH, Millar SE, Robey F, Dean J, Allen P, Luo AM, Lou YH, Yule T, Tung KSK: Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. J Clin Invest 1992, 89:28-35.
6. Lou YH, Ang J, Thai H, McElveen F, Tung KSK: A ZP3 peptide vaccine induces antibody and reversible infertility without ovarian pathology. J Immunol 1995, 155: 2715-2720.
7. Byskov AG: Cell kinetic studies of follicular atresia in the mouse ovary. J Reprod Fertil 1974, 37:277-285.
8. Rankin T, Familari M, Lee E, Ginsberg A, Dwyer N, Blanchette-Mackie J, Drago J, Westphal H, Dean J: Mice homozygous for an insertional mutation in the Zp3 gene lack a zona pellucida and are infertile. Development 1996, 122:2903-2910.
9. Lou YH, McElveen F, Adams S, Tung KSK: Altered target organ. A mechanism of postrecovery resistance to murine autoimmune oophoritis. J Immunol 1995, 155:3667-3673.
10. Garza K, Griggs ND, Tung KSK: Neonatal injection of an ovarian peptide induces autoimmune ovarian disease in female mice: requirement of endogenous neonatal ovaries. Immunity 1997, 6:89-96. This paper documents the different consequences of neonatal injection of the zona pellucida peptide pZP3 (in incomplete adjuvant) in male mice as a foreign peptide, and in female mice as a self peptide. Male mice produce a Th2-biased response and do not develop disease in their ovarian grafts upon adult challenge. Females produce a mixed Th1/Th2 response and develop AOD five weeks after injection, unless their ovaries are removed between days two and seven of life, whereupon their response is similar to that of the male mice. The latter finding suggests the possibility that self antigens have an impact on the immune system early in ontogeny.
11. Jones CM, Callaghan JM, Gleeson PA, Mori Y, Masuda T, Toh BH: The parietal cell autoantigens recognized in neonatal thymectomy-induced murine gastritis are the alpha and beta subunits of the gastric proton pump. Gastroenterology 1991, 101:287-294. Published erratum appears in Gastroenterology 1992, 102:1829].
12. + ATPase-specific T cell response from day three thymectomized mice, and shows that such a T cell clone adoptively transfers autoimmune gastritis to athymic recipients.
13. Hanji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y: Identification of α-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997, 276:604-607. NFS mice with s/d mutation, thymectomized on day three of life, developed spontaneous fodrin. Interestingly, the salivary glands of the thymectomized mice had over-expression of α-fodrin in the duct epithelium; both sialoadenitis and autoantibody response were prevented by neonatal in vitro injection of recombinant α-fodrin. Over 95% of patients with primary and secondary Sjogren's disease also had serum antibody to α-fodrin.
14. Ohashi PS: T cell selection and autoimmunity: flexibility and tuning. Curr Opin Immunol 1996, 8:808-814.
15. Singh VK, Yamaki K, Abe T, Shinohara T: Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: induction of experimental autoimmune uveitis and lymphocyte crossreaction. Cell Immunol 1989, 122:262-273.
16. Luo AM, Garza KM, Hunt D, Tung KSK: Antigen mimicry in autoimmune disease: sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest 1993, 92:2117-2123.
17. Garza K, Tung KSK: Frequency of T cell peptide crossreaction determined by experimental autoimmune disease and autoantibody induction. 1995, J Immunol 155:5444-5448.
18. Gautam AM, Pearson CI, Smilek DE, Steinman L, McDevitt HO: A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis. J Exp Med 1992, 176:605-609.
19. Wraith DC, Bruun B, Fairchild PJ: Cross-reactive antigen recognition by an encephalitogenic T cell receptor. J Immunol 1992, 149:3765-3770.
20. Wucherpfenning KW, Strominger JL: Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995, 80:695-705.
21. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM: Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995, 2:655-663.
22. Quaratino S, Thorpe CJ, Travers PJ, Londei M: Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc Natl Acad Sci USA 1995, 92:10398-10402.
23. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, Wiesmuller KH: Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997, 185:1651-1659. This study uses a powerful tool, a combinatorial peptide library, to identify cross-reactive ligands for a human CD4+ T cell clone that recognizes the myelin basic protein (MBP) peptide amino acid 86-96. Sublibraries containing 220 11-mer peptides were used to dissect the antigen recognition pattern of the T cell clones. This method easily identified stimulatory ligands from both human and microbial peptides, some being more potent than the MBP peptide, The general conclusion reached is that T cell recognition of cognate antigen is degenerate, and mimicry can occur without necessarily sharing common residues.
24. Mamula MJ, Craft J: The expression of self antigenic determinants: implications for tolerance and autoimmunity. Curr Opin Imunol 1994, 6:882-886.
25. Roth R, Nakamura T, Mamula MJ: B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 1996, 157:2924-2931. Supports a study described in [20] which indicates that the injection of foreign cytochrome c along with murine cytochrome c breaks the tolerance to murine cytochrome c, and that the responsiveness is transferable by B cells. In this study, the authors document the failure to break tolerance in B cell deficient mice.
26. Biron CA, Gazzinelli RT: Effects of IL-12 on immune response to microbial infections: a key mediator in regulating disease outcome. Curr Opin Immunol 1995, 7:485-496.
27. Sabin EA, Kopf MA, Pearce EJ: Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996, 184:1871-1878. Describes a non T cell mechanism whereby an infection modifies T cell differentiation into a Th2 phenotype. Molecule(s) from Schistosoma mansoni eggs attract and activate mast cells and eosinophils and, via IL-5 and IL-4 production, stimulate a polarized Th2 response.
28. Acha-Orbea H, MacDonald HR: Superantigens of mouse mammary tumor virus. Annu Rev Immunol 1995, 13:459-486.
29. 1,222 has homology with the murine mammary tumor virus and encodes a superantigen that stimulates Vβ7 T cells-a population enriched in human insulitis.
30. Kaliyaperumal A, Mohan C, Wu W, Datta SK: Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 1996, 183:2459-2469.
31. James J, Gross T, Scofield LH, Harley JB: Immunoglobulin epitope spreading and autoimmune disease after peptide immnization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995, 181:453-461.
32. Reynolds P, Gordon TP, Purcell AW, Jackson DC, McCluskey J: Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La [SS-B] permits induction of systemic autoimmunity in normal mice. J Exp Med 1996, 184:1857-1870. Shows that mice immunized with a subdominant, but not a dominant, T cell epitope of mouse La/SSB produce autoantibodies to distant La/SSB epitopes, and to Ro/SSA. The study also supports T→B cell epitope spreading, involving endogenous antigen, as the mechanism of diversified autoantibody response to this group of lupus antigens.
33. Lou YH, Tung KSK: T cell peptide of a self protein elicits autoantibody to the protein antigen: implications for specificity and pathogenetic role of antibody in autoimmunity. J Immunol 1993, 151:5790-5799.
34. Lou YH, McElveen F, Garza K, Tung KSK: Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmunity pathogenesis and B cell tolerance. J Immunol 1996, 156:3535-3540. This paper, along with [27], uses the zona pellucida 3 (ZP3) peplide induced autoimmune ovarian disease (AOD) model to elucidate the following properties of autoantibody diversification: the induction of autoantibody production by the ZP3 T cell epitope or its mimic; the recognition of the native ZP3 B cell epitope by, and the functionality of, the diversified autoantibodies; the requirement of endogenous antigen from normal ovaries for autoantibody induction; and, the rapid kinetics of the autoantibody response. The findings indicate that the specificity of the autoantibodies may not mirror the antigen that initiates an autoimmune disease, and that B cell tolerance to self antigens depends mainly on the lack of T cell help.
35. Fulcher DA, Lyons AB, Korn SL, Cook MC, Kileda C, Parish C, Fazekas de St Groth B, Basten A: The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 1996, 183:2313-2328.
36. Milich DR, Linsley PS, Hughes JL, Jones JE: Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model. J Immunol 1994, 153:429-435.
37. Griggs ND, Agersborg SS, Noelle RJ, Ledbetter JA, Linsley PS, Tung KSK: The relative contribution of the CD28 and GP39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self reactive T cells. J Exp Med 1996, 183:801-810.
38. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
39. Sudweeks JD, Todd JA, Blankenhorn EP, Wardell BB, Woodward SR, Meeker ND, Estes SS, Teuscher C: Locus controlling Bordetella pertussis-induced histamine sensitization [Bphs], an autoimmune disease susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc Natl Acad Sci USA 1993, 90:3700-3704.
40. Meeker ND, Mickey WF, Korngold R, Hansen WK, Sudweeks JD, Wardell BB, Griffith JS, Teuscher C: Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc Natl Acad Sci USA 1995, 92:5684-5688.
41. Teuscher C, Wardell BB, Lunceford JK, Michael SDS, Tung KSK: Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with II2, Fgfb, and Idd3. J Exp Med 1996, 183:631-637. Mapping study linking Aod2 to Idd3 and II2.
42. Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell 1996, 85:311-318.
43. Wardell BB, Michael SD, Tung KSK, Todd JA, Blankenhorn EP, McEntee K, Sudweeks JD, Hansen KW, Meeker ND, Griffith JS et al.: Aod1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16. Proc Natl Acad Sci USA 1995, 92:4758-4762.
44. Denny P, Lord CJ, Hill NJ, Goy JV, Levy ER, Podolin PL, Peterson LB, Wicker LS, Todd JA, Lyone PA: Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 1997, 46:695-700. Details the results of Idd3 congenic and physical mapping studies of Idd3 placing the gene within a 0.35 centimorgan interval encoding II2. In addition, the study provides sequence analysis in support of IL-2 as a candidate gene for Idd3.
45. Nair S, Caspi RR, Nelson LM: Susceptibility to murine experimental autoimmune oophoritis is associated with genes outside the major histocompatibility complex [MHC]. Am J Reprod Immunol 1996, 36:107-110.
46. Gorham JD, Guler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich W, Murphy KM: Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 1997, 93:12467-12472. Reports the mapping of a locus, Tpm1, controlling the differential induction of Th1/Th2 type responses. The results place it within a region of chromosome 11 encoding a variety of interleukins, chemokines, and which was previously mapped as an autoimmune disease susceptibility loci containing Orch2 and Idd4.
47. Dominant immunological tolerance. Immunol Rev 1996, 149:5-243.
48. Taguchi O, Takahashi T, Seto M, Namikawa R, Matsuyama M, Nishizuka Y: Development of multiple organ-localized autoimmune diseases in nude mice after reconstitution of T cell function by rat fetal thymus graft. J Exp Med 1986, 164:60-71.
49. Sakaguchi S, Ermak TH, Toda M, Berg LJ, Ho W, Fazekas de St Groth B, Peterson PA, Sakaguchi N, Davis MM: Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression. J Immunol 1994, 152:1471-1484.
50. Nishizuka Y, Sakakura T: Thymus and reproduction: sex dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969, 166:753-755.
51. Penhale WJ, Farmer A, McKenna RP, Irvine WJ: Spontaneous thyroiditis in thymectomized and irradiated wistar rats. Clin Exp Immunol 1973, 15:225-236.
52. Tung KSK, Taguchi O, Teuscher C: Testicular and ovarian autoimmune diseases. In Autoimmune Disease Models: A Guide Book. Edited by Cohen IR, Miller A. New York: Academic Press; 1994:267-290.
53. Sakaguchi S, Sakaguchi N: Thymus, T cells, and autoimmunity: various causes but a common mechanism of autoimmune disease. In Autoimmunity: Physiology and Disease. Edited by Coutinho A, Kazatchkine M. New York: Wiley-Liss; 1994:203-227.
54. Gleeson PA, Toh BH, van Driel IR: Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 1996, 149:97-125. An outstanding review of the autoimmune diseases induced by manipulation of the normal rodent immune system.
55. + T cells in BALB/c euthymic mice in vivo results in autoimmune disease development. Thus autoimmune disease in the manipulated mice has been shown to occur without either thymectomy or lymphopenia (O Taguchi, personal communication).
56. Smith H, Sakamoto Y, Kasai K, Tung KSK: Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 1991, 147:2928-2933.
57. - mature thymocyte population, which prevents disease in the manipulated rats, also transfers autoimmune ovarian disease to athymic recipients [58].
58. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T: Organ-specific autoimmune disease induced in mice by elimination of T cell subset I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 1985, 161:72-87.
59. Smith H, Lou YH, Lacy P, Tung KSK: Tolerance mechanism in ovarian and gastric autoimmune disease. J Immunol 1992, 149:2212-2218.
60. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chain [CD25]. Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
61. + T cells, more than three days after birth, further supports the speculation that thymectomy on day three induces autoimmune diseases by preventing regulatory T cell development.